These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 19217480)

  • 1. Epidemiology of hormone-related venous thromboembolism.
    Middeldorp S
    Thromb Res; 2009; 123 Suppl 2():S65-9. PubMed ID: 19217480
    [No Abstract]   [Full Text] [Related]  

  • 2. Prevention and treatment of hormone-associated venous thromboembolism: a patient management approach.
    Ueng J; Douketis JD
    Hematol Oncol Clin North Am; 2010 Aug; 24(4):683-94, vii-viii. PubMed ID: 20659653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Burden of atherosclerosis and risk of venous thromboembolism in patients with migraine.
    Sacco S; Carolei A
    Neurology; 2009 Jun; 72(23):2056-7; author reply 2057. PubMed ID: 19506237
    [No Abstract]   [Full Text] [Related]  

  • 4. Combination oral contraceptives and the risk of venous thromboembolism.
    Med Lett Drugs Ther; 2010 Mar; 52(1334):23-4. PubMed ID: 20336034
    [No Abstract]   [Full Text] [Related]  

  • 5. Oral contraceptives and the risk of breast cancer.
    Grant EC
    N Engl J Med; 2002 Oct; 347(18):1448-9; author reply 1448-9. PubMed ID: 12418035
    [No Abstract]   [Full Text] [Related]  

  • 6. [Vascular risks and HRT].
    Oger E
    Rev Prat; 2010 Oct; 60(8):1124. PubMed ID: 21197749
    [No Abstract]   [Full Text] [Related]  

  • 7. Hormone therapy. An update on risks and benefits.
    Mayo Clin Womens Healthsource; 2009 Mar; Suppl():1-8. PubMed ID: 19405167
    [No Abstract]   [Full Text] [Related]  

  • 8. Plasma leptin and adiponectin levels in hormone replacement therapy and contraception: effects of different progestogens.
    Di Carlo C; Tommaselli GA; De Rosa N; Fabozzi A; Santoro R; Bifulco G; Sparice S; Nappi C
    Fertil Steril; 2011 Jul; 96(1):214-9. PubMed ID: 21645895
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral contraceptives and venous thromboembolism: old questions revisited.
    Dinger J
    J Fam Plann Reprod Health Care; 2009 Oct; 35(4):211-3. PubMed ID: 19849911
    [No Abstract]   [Full Text] [Related]  

  • 10. Oral contraceptives and hormone replacement therapy: How strong a risk factor for venous thromboembolism?
    Skeith L; Le Gal G; Rodger MA
    Thromb Res; 2021 Jun; 202():134-138. PubMed ID: 33836493
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Oral contraception and hormone replacement therapy: management of their thromboembolic risk in the perioperative period].
    Chalhoub V; Edelman P; Staiti G; Benhamou D
    Ann Fr Anesth Reanim; 2008 May; 27(5):405-15. PubMed ID: 18472389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Hormonal treatment in women and thrombosis].
    Kaaja R; Heikinheimo O; Rasi V
    Duodecim; 1999; 115(11):1235-43. PubMed ID: 11877844
    [No Abstract]   [Full Text] [Related]  

  • 13. Association between antipsychotic drugs, antidepressant drugs, and venous thromboembolism.
    Lacut K
    Clin Adv Hematol Oncol; 2008 Dec; 6(12):887-90. PubMed ID: 19209139
    [No Abstract]   [Full Text] [Related]  

  • 14. Risk of VTE among users of oral contraceptives.
    Shapiro S; Dinger J
    J Fam Plann Reprod Health Care; 2010 Apr; 36(2):103. PubMed ID: 20406558
    [No Abstract]   [Full Text] [Related]  

  • 15. Coexisting venous thromboembolism in patients with tuberculosis.
    Sharif-Kashani B; Bikdeli B; Moradi A; Tabarsi P; Chitsaz E; Shemirani S; Esmaili-Khansari M; Masjedi MR
    Thromb Res; 2010 May; 125(5):478-80. PubMed ID: 20137804
    [No Abstract]   [Full Text] [Related]  

  • 16. Systemic lupus erythematosus.
    Grant EC
    Lancet; 2001 Aug; 358(9281):586. PubMed ID: 11526930
    [No Abstract]   [Full Text] [Related]  

  • 17. The pill and the pendulum.
    Schiff I
    Obstet Gynecol; 2007 Aug; 110(2 Pt 1):228-9. PubMed ID: 17666594
    [No Abstract]   [Full Text] [Related]  

  • 18. Oral contraceptives, hormone replacement therapy and haemostasis.
    Conard J; Samama MM
    Cephalalgia; 2000 Apr; 20(3):175-82. PubMed ID: 10997771
    [No Abstract]   [Full Text] [Related]  

  • 19. Secondary Polycythemia in Men Receiving Testosterone Therapy Increases Risk of Major Adverse Cardiovascular Events and Venous Thromboembolism in the First Year of Therapy. Reply.
    Ory J; Ramasamy R
    J Urol; 2022 Sep; 208(3):567. PubMed ID: 35648647
    [No Abstract]   [Full Text] [Related]  

  • 20. Secondary Polycythemia in Men Receiving Testosterone Therapy Increases Risk of Major Adverse Cardiovascular Events and Venous Thromboembolism in the First Year of Therapy. Letter.
    Kaplan-Marans E
    J Urol; 2022 Sep; 208(3):566-567. PubMed ID: 35648648
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.